黑种草种子提取物(Nigella sativa seed extract) - 在研适应症：慢性鼻窦炎_专利_临床

概要

基本信息

药物类型

中药

别名

Nigella sativa seeds extract containing ointment intervention

靶点-

作用机制-

治疗领域

感染耳鼻咽喉疾病呼吸系统疾病

在研适应症

慢性鼻窦炎

非在研适应症

砷性角化病新型冠状病毒感染糖尿病+ [4]

原研机构-

在研机构

Cairo University

非在研机构

Aga Khan UniversityHôpital Universitaire Sahloul

Bangabandhu Sheikh Mujib Medical University

+ [2]

最高研发阶段临床阶段不明

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

7

项与黑种草种子提取物相关的临床试验

NCT04767087 / Unknown status临床2/3期IIT

Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial

Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis

开始日期2021-03-05

申办/合作机构

Sheikh Zayed Federal Postgraduate Medical Institute

NCT04914767 / Completed临床1期IIT

The Effectiveness of Nigella Sativa in the Treatment of SARS COV2 (COVID-19)

The world is currently facing a crisis because of this potentially fatal situation of the COVID-19 epidemic without proven efficacy for any drug treatment, while the vaccination is not yet.
This epidemic is caused by a new betacorona virus, now called SARS-CoV-2. The most common symptoms reported are fever, cough or chest tightness, and dyspnea. Most cases have a mild course

开始日期2021-03-01

申办/合作机构

Hôpital Universitaire Sahloul

NCT04686461 / Unknown statusN/AIIT

Effect of Thymoquinone Extracted From Nigella Sativa in the Treatment of Arsenical Keratosis

Prepare an ointment from Nigella sativa seeds extract and apply it over palmer arsenical keratosis patient for 12 weeks. After than the effect of the ointment will be observed by measuring the keratotic nodular size before and after the intervention.

开始日期2019-10-20

申办/合作机构

Bangabandhu Sheikh Mujib Medical University

100 项与黑种草种子提取物相关的临床结果

登录后查看更多信息

100 项与黑种草种子提取物相关的转化医学

登录后查看更多信息

100 项与黑种草种子提取物相关的专利（医药）

登录后查看更多信息

214

项与黑种草种子提取物相关的文献（医药）

2024-10-01·Prostaglandins & Other Lipid Mediators

The effect of Nigella sativa supplementation on glycemic status in adults: An updated systematic review and meta-analysis of randomized controlled trials

Review

作者: Jamali, Mehrdad ; Shakarami, Mehrnaz ; Pam, Pedram

This systematic review and meta-analysis of randomized controlled trials (RCTs) sought to evaluate the effects of Nigella sativa (N. sativa) consumption on glycemic index in adults. A systematic literature search up to December 2023 was completed in PubMed, Scopus, and Web of Science, to identify eligible RCTs. Random effects models were assessed based on the heterogeneity tests, and pooled data were determined as weighted mean differences with a 95 % confidence interval. Finally, a total of 30 studies were found to be eligible for this meta-analysis. The pooled results using random effects model indicated that N. sativa supplementation significantly reduced FBS (SMD: -1.71; 95 % CI: -2.11, -1.31, p <0.001; I²= 92.7 %, p-heterogeneity <0.001) and HA1c levels (SMD: -2.16; 95 % CI: -3.04, -1.29, p <0.001; I²= 95.7 %, p-heterogeneity <0.001) but not effect on insulin (SMD = 0.48; 95 % CI: -0.53, 1.48, P = 0.353; I²= 96.1 %, p-heterogeneity <0.001), and HOMA-IR (SMD: -0.56; 95 % CI: -1.47, 0.35, p=0.229; I²= 95.0 %, p-heterogeneity <0.001).Overall, the evidence supports the consumption of N. sativa to reduce FBS and HA1c levels. Additional research, featuring extended durations and robust study designs, is necessary to determine the ideal dosage and duration of N. sativa supplementation for achieving a positive impact on glycemic markers.

2024-07-01·Heliyon

Manuka combinations with nigella sativa and hydroxyurea in treating iron overload of pediatric β-thalassemia major, randomized clinical trial

Article

作者: Elberry, Ahmed A ; Hussein, Raghda R S ; Abdelhalim, Shaimaa M ; Meabed, Mohamed Hussein ; Gamaleldin, Mohamed M ; Mahmoud Hussein, Ahmed F ; Abraham, Ivo L

Backgroundβ-thalassemia major is microcytic hypochromic anemia disorder inherited from parents, resulting from a mutation in the β-globin locus. As a result, a quantitative defective hemoglobin synthesis and relative excess in α-globin is occurred. As such, frequent blood transfusion is required, that leads to iron overload. Iron overload results in several pathological complications, including cell death, tissue injury, organ dysfunction, and liver fibrosis. The present study examined the effectiveness of nigella Sativa and manuka honey combination or manuka honey alone to the conventional therapy (Deferasirox + blood transfusion) used for preventing and managing iron overload in pediatric β-thalassemia major patients.MethodsOne hundred sixty-five patients participated in this randomized, double-blind, standard therapy-controlled, parallel-design multisite trial. The patients were randomly allocated into three groups, receiving either 500 mg nigella sativa oil combined with manuka honey lozenge (344 mg) daily or manuka honey alone plus the conventional therapy for ten treatment months. Ferritin level, serum iron, transferrin saturation, total iron binding capacity, alanine transaminase, and aspartate transaminase were determined at baseline and month 10.ResultsEventually, serum ferritin and iron were decreased significantly in the nigella sativa + manuka honey group as compared with the control group. Other clinical parameters were significantly impacted. The level of alanine transaminase and aspartate transaminase were significantly decreased in the nigella sativa plus manuka honey group compared with the control group.ConclusionResults showed that nigella sativa plus manuka honey was more effective than manuka alone or the conventional treatment alone in managing iron overload of β-thalassemia major patients.

2024-06-01·Clinical Nutrition ESPEN

Effects of Nigella sativa supplementation on lipid profiles in adults: An updated systematic review and meta-analysis of randomized controlled trials

Review

作者: Falahatzadeh, Maryam ; Vajdi, Mahdi ; Rounagh, Mahsa ; Hosseininejad-Mohebati, Ali ; Rostami, Reza Bijan ; Kavyani, Zeynab ; Musazadeh, Vali

BACKGROUND AND AIMSeveral experiments have suggested that Nigella sativa (N. sativa) supplementation may have a beneficial effect on the lipid profile. However, the results from these trials have been inconclusive. Therefore, this study aimed to explore the impact of N. sativa supplementation on the lipid profile of adult participants.METHODSWe searched Scopus, Web of Science, PubMed, Cochrane, and Web of Science databases until December 2022. Random effects models were used, and pooled data were determined as standardized mean differences with a 95% confidence interval.RESULTSThe findings of 34 studies with 2278 participants revealed that N. sativa supplementation significantly reduced total cholesterol (TC) (SMD: -1.78; 95% CI: -2.20, -1.37, p < 0.001), triglycerides (TG) (SMD: -1.2725; 95% CI: -1.67, -0.83, p < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD: -2.45; 95% CI: -3.06, -1.85; p < 0.001) compared to control groups. However, a significant increase was found in high-density lipoprotein cholesterol (HDL-C) (SMD: 0.79; 95% CI: 0.38, 1.20, p < 0.001).CONCLUSIONN. sativa has improved effects on TG, LDL-C, TC, and HDL-C levels. Overall, N. sativa may be suggested as an adjuvant anti-hyperlipidemic agent.

100 项与黑种草种子提取物相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
新型冠状病毒感染	药物发现	巴基斯坦	Sheikh Zayed Federal Postgraduate Medical Institute	2021-03-05
砷性角化病	药物发现	孟加拉国	Bangabandhu Sheikh Mujib Medical University	2019-10-20
血脂障碍	药物发现	印尼	University of Indonesia	2011-09-01
糖尿病	药物发现	巴基斯坦	Aga Khan University	2006-02-01
高胆固醇血症	药物发现	巴基斯坦	Aga Khan University	2006-02-01
高血压	药物发现	巴基斯坦	Aga Khan University	2006-02-01
代谢综合征	药物发现	巴基斯坦	Aga Khan University	2006-02-01